Not Disclosed

Drug Name: Not Disclosed
Company: miCure Therapeutics
Location: Israel
Drug Type: Gene Therapy
Conditions: ALS
Mechanism Type: MicroRNA therapeutics
Mechanism: miCure Therapeutics is developing microRNA-based therapeutics for CNS disorders. The company is pursuing an approach to treat ALS by restoring microRNA expression to their endogenous levels.
U.S. Status for ALS: Preclinical

[1] miCure Therapeutics Areas of Focus. miCure Therapeutics, 2013. Accessed 11 Mar 2016 from!-areas-of-focus/caob

Last updated March 11th, 2019

Share this: